Hepatic Tissue Engineering I

Moderator(s)

• 

  Chao Ma, PhD (he/him/his)

  Research Assistant Professor
  New York University Tandon School of Engineering
  New York, New York, United States
• 

  Donny Hanjaya-Putra

  Assistant Professor
  University of Notre Dame
  Notre Dame, Indiana, United States

Keynote Speaker(s)

• 

  Linda Griffith

  Professor
  MIT
  Cambridge, Massachusetts, United States

Presentations:

• 8:00 AM – 8:30 AM PDT

  Humanizing Drug Development by Modeling the Liver (And Its Neighborhood)
  

  Keynote Speaker: Linda Griffith, PhD – Massachusetts Institute of Technology
• 8:45 AM – 9:00 AM PDT

  Engineering a More Physiologically Relevant, Vascularized Model of Hepatic Insulin Resistance
  

  Presenting Author: Erin Tevonian – Massachusetts Institute of Technology

  Co-Author: Ellen L. Kan (she/her/hers) – MIT

  Co-Author: Alex Wang, PhD – Gensaic

  Co-Author: Douglas Lauffenburger, PhD – MIT

  Primary Investigator: Linda G. Griffith – MIT
• 9:00 AM – 9:15 AM PDT

  Engineering Strategies to Expand and Re-differentiate Primary Human Hepatocytes for Drug Screening
  

  Presenting Author: Vedant Vijay Bodke (he/him/his) – University of Illinois Chicago

  Co-Author: Chase Monckton – University of Illinois Chicago

  Last Author: Salman R. Khetani (he/him/his) – University of Illinois Chicago
• 9:15 AM – 9:30 AM PDT

  Engineering a Multicellular Induced Pluripotent Stem Cell-derived Human Liver Model for Drug Screening
  

  Presenting Author: Vedant Vijay Bodke (he/him/his) – University of Illinois Chicago

  Co-Author: Jennifer Liu (she/her/hers) – University of Illinois at Chicago

  Last Author: Salman R. Khetani (he/him/his) – University of Illinois Chicago